期刊
SLAS DISCOVERY
卷 23, 期 2, 页码 174-182出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/2472555217734128
关键词
Aminoacyl-tRNA synthetase (ARS); aminoacylation; protein-synthesis inhibitor; translation inhibitor; high-throughput screening (HTS)
资金
- National Institutes of Health [GM100136, GM106134]
- PGA National Women's Cancer Awareness foundation
- Korean Global Frontier Project [NRF-M1AXA002-2010-0029785]
Aminoacylation has been implicated in a wide variety of cancers. Aminoacyl-tRNA synthetases (ARSs) exist in large excess in tumor cells due to their increased demand for translation, whereas most other protein-synthesis apparatuses are quantitatively limited. Among other components that constitute the translation machinerynamely, tRNA, amino acid, ATP, and ARSARS is the only target that can be blocked by small molecules. No constitutively active ARSs have been reported, and mutations of ARS can cause inaccurate substrate recognition and malformation of the multi-ARS complex (MSC). Hence, interference of the activity is expected to be independent of genotype without developing resistance. Here, we report a high-throughput screening (HTS) system to find mammalian ARS inhibitors. The rabbit-reticulocyte lysate we used closely resembles both the individual and complexed structures of human ARSs, and it may predispose active compounds that are readily applicable for humankind. This assay was further validated because it identified familiar translational inhibitors from a pilot screen, such as emetine, proving its suitability for our purpose. The assay demonstrated excellent quality control (QC) parameters and reproducibility, and is proven ready for further HTS campaigns with large chemical libraries.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据